Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications

Strezova, AnaAnaStrezovaDíez Domingo, JavierJavierDíez DomingoCunningham, Anthony L.Anthony L.CunninghamEto, TakashiTakashiEtoAndrews, CharlesCharlesAndrewsArns, ClovisClovisArnsChoo, Eun-JuEun-JuChooHui, David Shu CheongDavid Shu CheongHuiIcardi, GiancarloGiancarloIcardiMcNeil, Shelly A.Shelly A.McNeilPõder, AiriAiriPõderKosina, PavelPavelKosinaRombo, LarsLarsRomboSchwarz, Tino F.Tino F.SchwarzTinoco, Juan CarlosJuan CarlosTinocoCHONG-JEN YUWang, JingJingWangSoni, JyotiJyotiSoniTsang, ManyeeManyeeTsangLeon, RafaelRafaelLeonMwakingwe-Omari, AgnesAgnesMwakingwe-Omari2025-07-072025-07-072025-05https://scholars.lib.ntu.edu.tw/handle/123456789/730623Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complicationsjournal article10.1016/j.eclinm.2025.103241